Can a suspected leiomyoma (uterine fibroid) identified on a computed tomography (CT) scan and ultrasound be cancerous?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a Suspected Leiomyoma on CT and Ultrasound Actually Be Cancer?

Yes, a suspected leiomyoma on CT and ultrasound can be cancer, as no pelvic imaging technique—including ultrasound and CT—can reliably differentiate between benign leiomyomas and leiomyosarcomas. 1

Key Diagnostic Limitations

Ultrasound Cannot Definitively Exclude Malignancy

  • Ultrasound lacks the ability to distinguish between benign leiomyomas and malignant leiomyosarcomas with certainty, despite being the first-line imaging modality for suspected fibroids 1
  • Color Doppler evaluation can identify vessels within lesions but cannot definitively differentiate between benign and malignant conditions 2, 3
  • Sonohysterography can characterize focal abnormalities but similarly cannot distinguish benign pathology from cancer with high certainty 2, 3

CT Has Limited Diagnostic Value

  • CT pelvis has no established role in differentiating benign from malignant uterine masses 2
  • Cases exist where CT suggested leiomyosarcoma but pathology revealed benign leiomyoma, demonstrating the unreliability of CT for this distinction 4, 5

Superior Imaging for Malignancy Detection

MRI Is the Gold Standard

  • MRI demonstrates superior capabilities for identifying malignant uterine pathology with sensitivity and specificity up to 100% and 100% respectively for leiomyosarcomas (compared to 79% and 89% for endometrial cancer) 2, 3
  • Diffusion-weighted MRI sequences specifically help differentiate leiomyosarcoma from benign leiomyoma and should be strongly considered 2, 6, 7
  • MRI with gadolinium-based contrast is preferred when evaluating for potential malignancy 2

Clinical Red Flags Requiring Heightened Suspicion

Warning Signs for Malignant Transformation

  • Rapid fibroid growth with tenderness in postmenopausal women should raise suspicion for leiomyosarcoma, though rare, and warrants urgent referral 6
  • Giant pedunculated subserous masses with fatty degeneration can mimic malignancy on imaging 4
  • Cachexia combined with a large abdominal mass may suggest malignancy but can still represent benign leiomyoma 5

Recommended Diagnostic Algorithm

When Leiomyoma Is Suspected on Initial Imaging

  1. Perform transvaginal and transabdominal ultrasound with Doppler as the initial evaluation 6, 1
  2. If ultrasound findings are suspicious, inconclusive, or the patient has concerning clinical features (postmenopausal, rapid growth, pain), proceed directly to MRI with contrast and diffusion-weighted sequences 2, 6, 7
  3. Do not rely on CT for distinguishing benign from malignant uterine masses 2

Specific Imaging Features to Document

  • Size, location, and number of masses 1
  • Presence of acoustic shadowing (typical for benign leiomyomas) 1
  • Vascular patterns on Doppler (though not definitive) 2
  • Any rapid interval growth on serial imaging 6

Critical Pitfalls to Avoid

  • Never assume a mass is benign based solely on ultrasound or CT appearance—these modalities cannot exclude leiomyosarcoma 1
  • Do not attribute new-onset tenderness to pre-existing fibroids without excluding complications or alternative diagnoses 6
  • Avoid relying on imaging alone when clinical suspicion for malignancy exists—tissue diagnosis may be necessary 2, 3
  • Large fibroids can displace normal ovaries and obscure visualization, potentially missing concurrent pathology 6

References

Research

Ultrasonography of uterine leiomyomas.

Przeglad menopauzalny = Menopause review, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Detection of Uterine Cancer on Pelvic Ultrasound

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A Case of Giant Uterine Lipoleiomyoma Simulating Malignancy.

Case reports in obstetrics and gynecology, 2015

Guideline

Uterine and Adnexal Tenderness in Fibroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Post-Endometrial Ablation Complications: Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.